Prostate Cancer - Results from #28020

AUA 2011 - Gay men more vulnerable to quality of life impacts following prostate cancer - Press Release May 15, 2011

Patient acceptance of active surveillance as a treatment option for low-risk prostate cancer - Abstract May 13, 2011

Comparison of risk calculators from the Prostate Cancer Prevention Trial and the European Randomized Study of Screening for Prostate Cancer in a contemporary Canadian cohort - Abstract May 13, 2011

Progression of metastatic castrate-resistant prostate cancer: Impact of therapeutic intervention in the post-docetaxel space - Abstract May 13, 2011

Race and survival following brachytherapy-based treatment for men with localized or locally advanced adenocarcinoma of the prostate - Abstract May 13, 2011

Urethra-sparing, intraoperative, real-time planned, permanent-seed prostate brachytherapy: Toxicity analysis - Abstract May 13, 2011

Prostate contouring variation: Can it be fixed? - Abstract May 13, 2011

Impact of the EpCAM expression on biochemical recurrence-free survival in clinically localized prostate cancer - Abstract May 13, 2011

Physiopathology and new therapeutic strategies in the management of bone metastases of prostate cancer - Abstract May 13, 2011

Outcome after conformal salvage radiotherapy in patients with rising prostate-specific antigen levels after radical prostatectomy - Abstract May 13, 2011

Human collagen injections to reduce rectal dose during radiotherapy - Abstract May 13, 2011

Critical assessment of the European Association of Urology guideline indications for pelvic lymph node dissection at radical prostatectomy - Abstract May 12, 2011

Difference in willingness-to-pay for prostate cancer screening between ill-informed and well-informed men: A contingent valuation survey - Abstract May 12, 2011

Time to castration resistance is an independent predictor of castration-resistant prostate cancer survival - Abstract May 12, 2011

Investigative clinical study on prostate cancer part IV: Exploring functional relationships of total testosterone predicting free testosterone and total prostate-specific antigen in operated prostate cancer patients - Abstract May 12, 2011

Whole-body MRI including diffusion-weighted imaging (DWI) for patients with recurring prostate cancer: Technical feasibility and assessment of lesion conspicuity in DWI - Abstract May 12, 2011

MRI-guided prostate biopsy detects clinically significant cancer: Analysis of a cohort of 100 patients after previous negative TRUS biopsy - Abstract May 12, 2011

Clinical efficacy of primary combined androgen blockade for Japanese men with clinically localized prostate cancer unsuitable for local definitive treatment: A single institution experience - Abstract May 12, 2011

Updating the prostate cancer risk indicator for contemporary biopsy schemes - Abstract May 12, 2011

Prostate adenocarcinoma with orbital metastasis in an HIV+ man - Abstract May 12, 2011

Page 1402 of 1437